Search for: "Amgen Inc. v. Sanofi"
Results 81 - 100
of 110
Sort by Relevance
|
Sort by Date
6 Oct 2017, 2:34 pm
Finding for Sanofi, the court held the sentence to be improper, relying heavily on its decision in Centocor Ortho Biotech, Inc. v. [read post]
6 Oct 2017, 8:20 am
By Dennis Crouch Amgen v. [read post]
6 Jan 2017, 8:51 am
See Amgen v. [read post]
18 Mar 2016, 7:47 am
" Amgen Inc. et al v. [read post]
23 Oct 2015, 2:58 pm
Robinson in Amgen Inc. v. [read post]
22 Oct 2015, 8:42 am
FDA beforeas the latest First Amendment follow-up action to Amarin Pharma, Inc. v. [read post]
12 Dec 2014, 10:29 pm
" Sanofi-Synthelabo v. [read post]
1 Mar 2014, 8:55 pm
In support thereof, Sanofi directed the Court’s attention to Amgen v. [read post]
13 Nov 2013, 8:40 pm
In Enzo Biochem, Inc. v. [read post]
2 Dec 2011, 2:00 pm
Amgen, Inc., ___ F. [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen,… [read post]
31 Aug 2010, 10:01 pm
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
18 Mar 2010, 2:30 am
Amgen, Inc. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
1 Dec 2009, 9:45 am
Amgen Inc. and Wyeth (patent infringement) 10/28: Deston Therapeutics LLC, Unigen Pharmaceuticals Inc. v. [read post]
12 Dec 2008, 8:42 am
See Amgen Inc. v. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
